Optablate
Payments companies reported to CMS as associated with Optablate. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Optablate, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Optablate
These are the largest totals companies reported as associated with Optablate. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sean Tutton | San Diego, CA | Vascular & Interventional Radiology | $104,532.33 |
| Jason Levy | Atlanta, GA | Vascular & Interventional Radiology | $74,759.19 |
| Jad Khalil | Southfield, MI | Orthopaedic Surgery | $68,847.71 |
| Douglas Beall | Edmond, OK | Diagnostic Radiology | $63,116.04 |
| Anthony Brown | Englewood, CO | Vascular & Interventional Radiology | $45,646.47 |
| Jason Dunleavy | Williamsville, NY | Diagnostic Radiology | $39,382.59 |
| Brandon Key | Milwaukee, WI | Vascular & Interventional Radiology | $38,762.79 |
| Milan Patel | Houston, TX | Vascular & Interventional Radiology | $35,843.14 |
| Majid Khan | Baltimore, MD | Neuroradiology | $28,835.32 |
| Vishal Khemlani | Tualatin, OR | Pain Medicine (Anesthesiology) | $24,854.80 |
Prescribed Optablate?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.